India POCT Market Outlook to 2023: Ken Research

1
India POCT Market Outlook to 2023 - By Major
Devices (Blood Glucose Testing Kits, Infectious
Disease Testing Kits, Blood Gas Electrolytes,
Pregnancy and Fertility Testing Kits, Cardio
Metabolic Monitoring, Anticoagulant Management,
Cholesterol Testing Kits and Others), By End
Users (Hospitals Clinics, Consumers/
Individuals, Diagnostic Labs, Home Healthcare and
Others), By Distribution Channel (Distributors
and Direct Sales), By Consumables and Instruments
and By Region

• May 2019

2
Table of Contents (1/2)
1. Executive Summary 1.1. Current Scenario 1.2.
Future Projections 2. Research Methodology 2.1.
Market Definitions 2.2. Abbreviations 2.3.
Consolidated Research Approach 2.4. Variables
(Dependent and Independent) 2.5. Correlation
Matrix 2.6. Regression Matrix 2.7. Limitations
and Conclusion 3. Value Chain Analysis of India
POCT Market 3.1. Overview 3.2. Networking 4.
Indian National Health Account Statistics 5.
Market Overview and Genesis 5. 1. Market Time
Line 6. India POCT Market Size- Current and
Future Scenario 6.1. By Historical Revenue,
FY2013- FY2018 6.2. By Forecasted Revenue,
FY2018- FY2023 7. India POCT Market
Segmentation- Current and Future scenario 7.1.
By Major Devices (Blood Glucose Testing Kits,
Infectious Disease Testing Kits, Blood Gas
Electrolytes, Pregnancy and Fertility Testing
Kits, Cardio Metabolic Monitoring, Anticoagulant
Management, Cholesterol Testing Kits and Others),
FY2018- FY2023E 7.1.1. Blood Glucose Testing
Kits 7.1.2. Infectious Disease Testing Kits
7.1.3. Blood Gas Electrolytes 7.1.4. Pregnancy
and Fertility Testing Kits 7.1.5. Cardio
metabolic Monitoring 7.1.6. Anticoagulant
Management 7.1.7. Cholesterol Testing Kits
7.1.8. Others 7.2. By End Users (Hospitals
Clinics, Consumers/ Individuals, Diagnostic Labs,
Home Healthcare and Others), FY2018-
FY2023E 7.3. By Consumables and Instruments,
FY2018-FY2023E 7.4. By Distribution Channel
(Distributors and Direct Sales), FY2018  7.5. By
Region (Tier 1, Tier 2 and Tier 3 Cities),
FY2018 and FY2023E 8. Trends and Development
of India POCT Market
3
Table of Contents (2/2)
9. Issues and Challenges of India POCT Market
10. Government Regulations for India POCT Market
10.1. Regulations for IVD Medical Devices 10.2.
Regulatory Approval Process for Manufacture for
Sale/Distribution of Medical Devices 10.3.
Procedure to Apply for Import of Medical
Devices 10.4. Fees and Charges for Medical
Devices in India 10.5. List of Application Forms
Required to Apply for Medical Devices Approval
10.6. List of Documents required with the
Application for Grant of License to Manufacture
or import of Medical Device 11. Trade Scenario of
the India POCT Market 11.1. Import Value and
Importing Countries, FY2014-FY2018 11.2. Export
Value and Destinations of POCT Devices by India,
FY2014-FY2018 11.3. Cross Comparison between
Domestic Production and Import of POCT Devices
(Major Products Manufactured in India, Major
Imported Products, Major Manufacturers in India,
Initiatives for manufacturing and others),
FY2018 11.4. Manufacturing Units of major POCT
Device Manufacturers in India 12. Funding and
Mergers and Acquisitions Scenario in the India
POCT Market 13. Customer Decision Parameters in
India POCT Market 14. Porters Five Forces in
India POCT Market 15. Competition Landscape of
India POCT Market 15.1. Competitive Scenario
(Competing Parameters, Major Players and
Competition Structure) 15.2. Market Share of
Major Players - By Revenue, FY2018 16. Strength
and Weaknesses of Major Players in India POCT
Market 17. Company Profiles of Major Players in
India POCT Market including (Company Overview,
Business Model, Strengths, Market Share, Key POCT
Devices Offered, Total Income from All Brands,
Financials, Mergers and Acquisitions and Product
Profile) 17.1. Abbott India Limited 17.2. Roche
Diagnostics 17.3. Siemens Healthcare Private
Limited 17.4. Beckman Coulter India Pvt Ltd
17.5. J Mitra co. Pvt. Ltd. 17.6. Trans Asia
Bio Medical 17.7. Radiometer India 17.8. Bio Rad
Laboratories 17.9. DiaSys India 17.10. Other
Companies (EKF Diagnostics, Renesas Electronics,
Triviton Healthcare Private Limited, Becton
Dickinson India Private Limited and India
Medtronic Private Limited) 18. Upcoming
Technologies in India POCT Market 19. India POCT
Market - Analysts Recommendations Disclaimer
Contact Us
4
1. Executive Summary
5
1.1 Executive Summary (1/3)
Figure 1.1 India POCT Market Size on the basis
of Revenue in INR Crore and Growth Rate in
Percentage (), FY2013- FY2018 and FY2023E

• License Rights
• Excel Only USD 2000
• Single User USD 2500
• Hard Copy USD 3100
• Single and Excel USD 3500
• Enterprise Wide USD 5000
• Slides 152
• Related Reports
• India Home Healthcare Market Outlook To 2023 - By
  Patient Profile (Elderly Care, Physiotherapy,
  Stroke Rehabilitation, Wound Care And Others) By
  Organized (Subscription And Non Recurring Model)
  And Unorganized, By Major Cities
• India Diagnostic Laboratories Market Outlook To
  2021 Growing Prevalence Of Diseases And Launch Of
  Technologically Advanced Procedures To Drive
  Growth
•   
• Europe POCT Devices Market Outlook To 2022 - By
  Geography (Western Europe Eastern Europe), By
  Product (Blood Glucose POCT, Infectious POCT,
  Cardiac POCT, Rapid Coagulation POCT, Blood Gas
  Electrolytes POCT, Hematology POCT, Pregnancy
  POCT, Urinalysis POCT, Cholesterol POCT, Fecal
  Occult POCT, Hb1ac POCT Drugs Of Abuse POCT),
  By Customer Segments (Hospitals Clinics,
  Diagnostics Labs Primary Care Units And
  Homecare Patients)

Source Company Website, Ken Research Analysis
CAGR (FY2013-FY2018)
CAGR (FY2018-FY2023E)
Growing Stage
Moderately Concentrated
CAGR (Revenue)
Cost, Expertise, Brand, Ease of Use and Key
Products Offered
Market Structure
6
1.2. Executive Summary Current Scenario

• Key Takeaways
• The India POCT Market is currently at its growing
  stage where new companies are setting up their
  units in the country.
• The India POCT market has witnessed an increased
  amount of investment and MA activities.
• Since India is an emerging market for POCT
  device manufacturers, the lack of central
  laboratories drives the growth for these devices.
  Along with this, India constitutes of large rural
  communities and hence the incidences for
  infectious diseases are more.
• The elderly population in India have been
  increasing and hence there can be seen a need for
  handy rapid diagnosing devices which ensure
  faster treatment and a reduced number of hospital
  visits.

Figure 1.1 Flowchart for India POCT Market,
FY2018
CAGR FY2013-FY2018
Market Structure Moderately Concentrated
CAGR for Elderly Population ( FY2012- FY2017)
7
1.3. Executive Summary - Future Projections
Figure 1.2 Flowchart for Future Projection of
India POCT Market, FY2018- FY2023E

• Key Takeaways
• The India POCT market is expected to grow at an
  enormous rate owing to factors such as
  compactness, portability and its usage by the non
  laboratory personnel in the purview of getting
  faster results.
• The major players operating in the market include
  Abbott's India, Roche Diagnostics, J Mitra Co.
  Transasia Bio Medical, Bio Rad Laboratories,
  Siemens Healthcare Private Limited, Radiometer
  India and others.
• Launch of various new products in different
  product genre is anticipated to expand the target
  audience. Increasing internet penetration
  higher number of smart phones users are likely to
  boost online sales in the country.
• The growth in the POCT market is likely to be
  driven by more product acceptance by retail
  customers along with increased reliability and
  trust in the POCT devices by hospitals and as
  well as individuals.

CAGR FY2018-FY2023E
CAGR FY2017-FY2022E
8
6. India POCT Market Size- Current and Future
Scenario
9
6.1. By Historical Revenue, FY2013- FY2018
Figure 6.1 India POCT Market Size on the basis
of Revenue in INR Crore and Growth Rate in
Percentage (), FY2013- FY2018

• Key Takeaways
• Increase in the Prevalence of Chronic Diseases
  There has been an increase in the number of
  Acute Diseases amongst the Indian population in
  the recent years. Alongside this the prevalence
  of Chronic Illness such as Cancer has also been
  on a rise lately. The estimated cases of Cancer
  for the FY2016 stood at which grew to being
  in the FY2018. Increases of these diseases at
  such a large scale has pushed the use of POCT
  devices in India. One of the growth drivers for
  the POCT market also includes the elderly
  population in India which stood at Millions in
  the FY2018. The age specific chronic diseases
  such as Diabetes Mellitus has driven the sale of
  blood glucose testing kits.
• The study, which provides the first-of-its-kind
  nationally representative estimates of
  cardiovascular mortality in India, shows that
  heart ailments caused more than 2.1 million
  deaths in India in 2015 at all ages, or more than
  a quarter of all deaths. At ages 30-69 years, of
  1.3 million cardiovascular deaths, 0.9 million
  (68.4) were caused by coronary heart disease and
  0.4 million (28.0) by stroke.
• Advancement in Medical Knowledge and RD With
  major manufacturers noticing increase in per
  capita spending on healthcare by individuals,
  developing new and handy POCT methods/devices
  has been on rise. Mergers Acquisitions,
  acquiring patents and high competition for market
  dominance has been prevalent.
• Unease Associated with Laboratory Testing
  Methods Easy convenient managing of obesity
  and cardiovascular related diseases fertility
  related issues, POCT devices have become a way
  out for people to get faster and cheaper
  detection method in comparison to cumbersome
  laboratory diagnostics. Pathology related
  diagnostics test have been performed at home with
  ease moreover, diagnostic lab test have become
  POCT-friendly, providing results within minutes.
  This has encouraged households to opt for these
  devices for early detection hence, early
  treatment.
• New companies venturing the market With vast
  scope of innovation and expansion, many new
  companies have been expanding their product lines
  into POCT device manufacturing. Witnessing
  highly profitable business associated with a
  successful new technology in POCT market,
  attracts new players.

CAGR During FY2013- FY2018
Overall Market Stage
Total Number of Patients Suffering from stroke
amount to million in 2018 out of which ()
were in the age range of 18-45 years
10
6.2. By Forecasted Revenue, FY2018- FY2023E
Figure 6.2 India POCT Market Future Outlook and
Projection on the basis of Revenue in INR Crore
and Growth Rate in Percentage (), FY2018-
FY2023

• Key Takeaways
• The India POCT market is expected to grow at an
  enormous rate owing to factors such as
  compactness, portability and its usage by the non
  laboratory personnel in the purview of getting
  faster results.
• India has been a country with one of the highest
  number of Diabetic patients in the world and as
  per the International Federation of Diabetes, the
  numbers are likely to increase to Million by
  2025. Such alarming numbers have enabled the
  people to become proactive and keep a check on
  their Glucose levels, not just for treatment
  purposes but also as a preventive measure.
• The elderly population in India is one of target
  end users for the home healthcare companies and
  overall POCT market in general. Increase in
  incidence of diseases such as HIV, Infectious and
  Cardiac will lead to strong growth of Infectious
  and Blood Glucose POCT devices.
• Growth in POCT market in the country is most
  likely to be influenced by increase in the number
  of new entrants in the market, larger product
  acceptance by retail customers, increase in
  reliability trust in POCT devices by home users
  hospitals, expanding distribution channels and
  higher marketing expenditure by the companies.
• Launch of various new products in different
  product genre is anticipated to expand the target
  audience. Increasing internet penetration
  higher number of smart phones users are likely to
  boost online sales in the country.
• Upcoming fields Ocular Point-of-care, Traumatic
  Brain Injury (focused on developing POC for
  concussion management to assess the extent of
  brain damage following trauma), Rare Diseases
  (One example is a rapid POC device for sickle
  cell disease from Medomics), Neuropsychiatry
  Disorders detection (such as Alzheimers,
  Schizophrenia), Molecular Diagnostics and
  Oncology (chemotherapy for disease progression
  using POC tests)

Future Projection of Market Stage
CAGR During FY2018- FY2023E
Projected Elderly Population in India, FY2023
Million
11
7. India POCT Market Segmentation- Current and
Future scenario
By Major Devices By End Users By Consumables
and Instruments By Distribution Channel By Region
12
7.1. By Major Devices (Blood Glucose Testing
Kits, Infectious Disease Testing Kits, Blood Gas
Electrolytes, Pregnancy and Fertility Testing
Kits, Cardio Metabolic Monitoring, Anticoagulant
Management, Cholesterol Testing Kits and Others),
FY2018- FY2023E
Figure 7.1 India POCT Market Segmentation by
Major Devices on the basis of Revenue (In
Percentages), FY2018-FY2023E
Table 7.1 India POCT Market Segmentation by
Major Devices on the basis of Revenue (In INR
Crore), FY2018-FY2023E
POCT Device Market Basis Major Devices FY'2018E FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E
Blood Glucose Testing Kits
Infectious Disease Testing Kits
Blood Gas Electrolytes
Pregnancy And Fertility Testing Kits
Cardio metabolic Monitoring
Anticoagulant Management
Cholesterol Testing Kits
Others
Total
The number of patients with diabetes mellitus is
expected to reach million in India and
million in China compared to million in U.S. by
2030.
CAGR (FY2018-FY2023E) for Blood Glucose
Testing
13
7.1.1. Blood Glucose Testing Kits (1/2)
Table 7.2 Blood Glucose POCT Devices Market
Segment Including Product Overview, Test Purpose,
Instrument Consumable, Market Size, Market
Future, Major Companies, Major Brands and Key
Weakness
Parameters Description
Product Overview
Test Purpose
Instrument Consumable
Market Size Related Numbers
Market Future
Major Companies
Major Brands
Key Weakness
14
7.1.1. Blood Glucose Testing Kits (2/2)
Key Strengths

• In the India POCT market, Blood Glucose Testing
  kits had the highest share of for the FY2018.
  This testing kit is a device used on a routine
  basis to monitor glucose levels for people at
  home or for patients under tight glycemic control
  requirements.

• Turn Around Time Refers to the total period from
  a clinicians issuance and delivery of order,
  collection, transportation and analysis of
  specimen and calculation, verification and
  delivery of results to review of results. A
  undisputed advantage of POCT for BG is the rapid
  turn-around time compared to CLT. POCT gives
  results in minutes while in CLT, it takes
  minutes.
• Patient Sample Volume POCT devices utilize very
  small volume of blood, µL, in contrast to CLT
  requiring mL of blood. For blood conservation
  in patients, it is advisable to use POCT Devices
  as the mean volume of blood loss per patient per
  admission due to POCT for BG is only ml however
  in CLT blood loss per patient per admission due
  to phlebotomy is between and mL (ICU Between
  600-700 mL).
• Common Issues with CLT Mislabeling patient
  sample, Lost sample, Contamination of sample,
  Degradation of sample due to delay in either
  transport or processing of sample after arrival
  at the laboratory and others.

• This high share owes to the fact that number of
  people suffering from Diabetes Mellitus have
  increased from being Million in the year 2013
  to Million in the year 2017. Hence more number
  of people are opting for such monitoring devices.

KEY FACTS

• Type II Diabetes is to times more prevalent
  in urban areas as compared to the rural areas
  due to factors such as obesity, insulin
  resistance and lifestyle changes owing to
  urbanization.

15
7.1.2. Infectious Disease Testing Kits
Table 7.3 Infectious POCT Devices Market Segment
Including Product Overview, Instrument
Consumable, Major Players, Market Size, Market
Future, Major Brands, Growth Strategies and
Technologies
Parameters Description
Product Overview
Instrument Consumer-able
Major Players
Market Size Numbers
Market Future
Major Brands
Company Growth Strategies
Technologies
16
7.1.3. Blood Gas Electrolytes
Table 7.4 Blood Gas Electrolytes Market Segment
Including Product Overview, Instrument
Consumable, Replacement Time, Market Size, Market
Future and Major Players
Parameters Description
Product Overview
Instrument Consumable
Replacement Time
Market Size
Market Future
Major Players
17
7.1.4. Pregnancy and Fertility Testing Kits
Table 7.5 Pregnancy And Fertility Testing Kits
Market Segment Including Segment Overview,
Product Details and Instrument Consumer-able,
Major Players, Major Products, Product related
difficulties faced by the consumers, Market Size
and Market Future
Parameters Description
Segment Overview
Product Details and Instrument Consumer-able
Major Players
Major Products
Market Size Related Numbers
Market Future
Product related difficulties faced by the consumers
18
7.1.5. Cardio metabolic Monitoring
Table 7.6 Cardio metabolic Monitoring POCT
Devices Market Segment Including Product
Overview, Instrument Consumable, Current Market
Trends, Major Players, Market Size, End Users,
Major Customers and Future Market Size
Parameters Description
Product Overview
Current Trends
Instrument Consumable
Market Size Related Numbers
Market Future
Major Customers
Major Players
Key End-user Groups
19
7.1.6. Anticoagulant Management
Table 7.7 Anticoagulant Management POCT Devices
Market Segment Including Segment Overview, Key
Strengths, Major Players, Major Products, End
Users, Market Size Related Numbers and Market
Future
Parameters Description
Segment Overview
Strengths
End Users
Market Size Related Numbers
Market Future
Major Players
Major Products
20
7.1.7. Cholesterol Testing Kits
Table 7.8 Cholesterol Testing Kits Market
Segment Including Product Overview, Instruments
and consumables, Major Players, Leading Product,
Market Size Related Numbers and Market Future
Parameters Description
Product Overview
Instrument Consumable
Market Size Related Numbers
Market Future
Major Players
Cholesterol Testing Kits CAGR
21
7.1.8. Others
Table 7.9 Other Products Market Segmentation
Including HbA1c, Drug of Abuse Testing Kits,
Urinalysis Testing Kits and Fecal Occult Testing
Kits.
Parameters Description
HbA1c
Drug of Abuse Testing Kits
Urinalysis Testing Kits
Fecal Occult Testing Kits
22
7.2. By End Users (Hospitals Clinics,
Consumers/ Individuals, Diagnostic Labs, Home
Healthcare and Others), FY2018- FY2023E (1/2)
Figure 7.2 India POCT Market Segmentation by End
Users on the basis of Revenue (in Percentages),
FY2018-FY2023E
Table 7.11 Cross Comparison of POCT Devices on
the Basis of End Users Including Key Users,
Revenue Generated Others
Parameter Customers and Individuals (B2C) Diagnostics Labs Primary Care Units (B2B) Hospitals Clinics (B2B)
Key Users
Revenue Generated (INR Million), FY18
POCT Devices Used
Purpose of Devices
Usual Tests Done For
Technology Used
Table 7.10 India POCT Market Segmentation by End
Users on the Basis of Revenue (in INR Crore),
FY2018-FY2023E
POCT Device Market Basis End Users FY'2018 FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E
Hospitals Clinics
Consumer/Individuals
Diagnostic Labs
Home Healthcare
Others
Total
23
7.2. By End Users (Hospitals Clinics,
Consumers/ Individuals, Diagnostic Labs, Home
Healthcare and Others), FY2018- FY2023E (2/2)
Hospitals and Clinics

• The hospitals and clinics are expected to grow
  at a CAGR of 11.0 for the period of FY2018-
  FY2023E and are expected to generate a revenue of
  INR 3600.0 Million from the POCT segment. The
  number of primary health centers operating in
  India as of FY2018 stands at 25,743 and the ones
  operating as per the IPHS norms are 3,052. These
  numbers are not sufficient to cater the
  increasing Indian population which is expected to
  be 1,365,302 for FY2023 and simultaneously the
  number of patients have also been on a rise. This
  serves as a growth driver for all the hospitals
  and clinics providing POCT solutions.

Consumers and Individuals

• The segment for consumers and individuals is
  expected to grow at a CAGR of 12.6 for the
  period of FY2018- FY2023E and is expected to
  generate a revenue of INR 4,477.7 Million for the
  FY2023. The growth drivers for the same includes
  the lifestyle changes inculcated by the
  individuals as they have become more proactive in
  nature. Individuals have been using POCT devices
  such as Cholesterol testing as a precautionary
  measure in order to prevent various cardiac
  diseases. Individuals are also considering
  genetic disorders and are using POCT devices as a
  move in the process of becoming health conscious.

Diagnostic Labs

• The diagnostic laboratories are expected to grow
  at a CAGR of 7.0 for the period of FY2018-
  FY2023E and the revenue generated by them form
  the POCT segment is valued at INR 1053.6 Million.
  There has been a significant increase in the
  number of people suffering from cancer in India
  wherein the number stood at 1,451,417 in the
  FY2016 and grew to 1,586,571 in the FY2018. The
  treatment for cancer requires certain tests which
  have to be conducted and those are facilitated by
  these diagnostic labs. A total of 95 (approx.)
  NABL accredited diagnostic labs are prevailing in
  India.

Home Healthcare

• The Home Healthcare segment is expected to grow
  at a CAGR of 18.5 for the period of FY2018-
  FY2023E and are expected to generate a revenue of
  INR 1,053.6 Million for the FY2023. This growth
  has been one of the highest amongst all the
  considered segments due to various growth drivers
  which include the need for elderly care, Stroke
  patients, post ICU care, post surgery care,
  mother and child care. The home healthcare
  market in India is dominated by the unorganized
  sector contributing INR 17,004.8 Crores, with an
  overall share evaluated at 80 of the total
  market size. It can be seen as an emerging
  segment as its still in its early growth stage
  and major players are still working on
  establishing their presence in major cities.

24
7.3. By Consumables and Instruments,
FY2018-FY2023E (1/2)
Figure 7.3 India POCT Market Segmentation by
Consumables and Instruments on the basis of
Revenue in Percentage (), FY2018- FY2023E
Table 7.13 Cross comparison on the Basis of
Consumables and Instruments including Definition,
Rationale and Average Replacement Rate,
Components included, Highest Product Category
Usage
Parameter Instruments Consumables
Definition
Rationale and Average Replacement Rate
Components included
Highest Product Category Usage
Table 7.12 India POCT Market Segmentation by
Consumables and Instruments on the basis of
Revenue for the Period of FY2018- FY2023 (in INR
Crore), FY2018-FY2023E
Consumables and Instruments FY'2018 FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E
Consumables (cartridges, test strips etc.)
Instruments (Main Device)
Total
25
7.3. By Consumables and Instruments,
FY2018-FY2023E (2/2)
Table 7.14 List of POCT products manufactured by
Alere, Abbott Ltd. And Roche Diagnostics Limited
Including Company, Best Seller Product, Diagnosed
Product Category and Instrument and Consumables
Used
Company Product (Best Seller) Diagnosed Product Category Instrument Consumable Used
Alere
Alere
Alere
Abott
Abott
Alere
Alere
Roche
Roche
Roche
Roche
Roche
26
7.4. By Distribution Channel (Distributors and
Direct Sales), FY2018
Figure 7.4 India POCT Market Segmentation by
Distribution Channel on the basis of Revenue in
Percentage, FY2018
Number of Pharmacies

• Key Takeaways
• Distributors They play a key role in the overall
  POCT market in India constituting of market
  share on the basis of revenue as of FY2018. The
  share of distributors include the distributors
  for end users and for retailers as well. The end
  users include the hospitals and clinics,
  diagnostic labs, individuals and home healthcare
  companies. These users conduct the POCT business
  on a large scale and in order to cater to such
  big clients, the POCT companies prefer to sell
  their devices through distributors. Alongside
  catering to these end users, POCT companies sell
  their devices through distributors to retailers
  such as small scale pharmacies. There were
  pharmacies in India as of FY2018.
• Margin of the distributors The distributors
  margin on the sale of consumables is valued at
  around to and the margin on the sale of
  instruments is valued at to .
• Major Distributors The major distributors in
  the India POCT market include BHR Diagnostics
  Pvt. Ltd.,
• Direct Sale The direct sale of POCT devices
  constitute only of the market share on the
  basis of revenue in FY2018. Majority of the POCT
  companies do not contact their clients directly
  and rather prefer using a medium to sell their
  products due to the high cost involved. It has
  also been observed that the companies might face
  difficulties while entering to new markets if
  they use direct sales over distributors. This
  corresponds to the fact that the major companies
  providing POCT devices in India have their
  origins in different other countries and in order
  to cater to the Indian market they choose to sell
  through distributors.

Table 7.15 India POCT Market Segmentation by
Distribution Channel on the Basis of Revenue in
INR Million, FY2018
Distribution Channel FY' 2018
Through Distributors to end users
Through Distributors to retailers
Directly
27
7.5. By Region (Tier 1, Tier 2 and Tier 3
Cities), FY2018 and FY2023E
Figure 7.5 Market Segmentation and Future
Projection by Region on the basis of Sales of
POCT Devices in Tier 1, Tier 2 and Tier 3 Cities
of India in Percentage (), FY2018 and FY2023E

• Key Takeaways
• The segmentation of the India POCT market by
  regions is based on the tier 1, tier 2 and tier 3
  cities of India. Tier 1 city includes the metro
  cities of the country including Delhi/NCR,
  Mumbai, Hyderabad, Bangalore, Chennai, and
  Kolkata.
• The sale of POCT devices is the highest in Tier 1
  cities followed by tier 2 cities owing to the
  factor that the countrys major Multi Specialty
  and Single Specialty hospitals are located in
  these cities and people from all over India visit
  them for accessing specialized treatment.
• The people residing in tier 1 and tier 2 cities
  have a higher personal disposable income as
  compared to other cities. Furthermore, the people
  in tier 1 cities are more aware about such
  devices and have an easy access to them.
• The sales of POCT devices is the highest in
  Delhi followed by Chennai as these are the hub
  for medical care patients. The countrys topmost
  Multi Specialty and Super Specialty Hospitals are
  located in these cities including Apollo
  Specialty Hospital in Chennai and All India
  Institute of Medical Sciences (AIIMS) in Delhi.
  POCT devices for diseases such as Cardiac
  diseases, stroke and diabetes are not only used
  by these hospitals but also by the patients
  visiting these hospitals for varied treatments in
  order to conduct regular self checkups.
• It has also been observed that the incidence of
  diseases such as Cardiac diseases, Diabetes, high
  Cholesterol and stroke are more in the urban
  areas of India owing to the lifestyle changes.
  Perhaps, this has encouraged the sales of POCT
  devices as people have started using POCT devices
  for regular self check-ups as well.
• Furthermore, it has been anticipated that the
  sale of POCT devices would reduce in Tier 1
  cities and in turn the sales would increase in
  the Tier 3 cities. The reasons behind this
  paradigm shift could possibly include the
  increasing awareness and government initiatives
  for improving the rural healthcare in Tier 3
  cities. For instance, one of the governments
  program named as Ayushman Bharat for rural
  healthcare betterment could seek more traction in
  the near future.
• The private companies entering the India POCT
  market have already started setting up their
  manufacturing units in Tier 2 and Tier 3 cities
  of India. For instance, companies such as Becton
  Dickinson India, Boston Scientiic Corp and others
  have set up their manufacturing units in various
  areas of Haryana and Chandigarh.

Table 7.16 Market Share (Estimated) of Each City
under Tier 1 in Percentage (), FY2018
City Market Share of Tier-1 cities (in ), FY2018
Delhi/NCR
Chennai
Mumbai
Bangalore
Hyderabad
Kolkata
Total
28
15. Competition Landscape of India POCT Market
29
15.1. Competitive Scenario (Competing Parameters,
Major Players and Competition Structure)
Key Metrics of India POCT Market

Market Stage
CAGR 2013-2018

Competitive Structure
Number of Companies operating
30
15.2. Market Share of Major Players - By Revenue,
FY2018
Table 15.1 Market Share of Major Players
Operating in the India POCT Market on the Basis
of Revenue in Percentage (), FY2018

• Key Takeaways
• The key players in the India POCT market include
  Abbott India Limited, Roche Diagnostics Limited,
  Siemens Healthineers, Johnson Johnson, J Mitra
  Co. Pvt. Ltd. and companies under Danaher
  Corporation operating in India.
• Taking into consideration the diversity of the
  POCT products offered in this segment, there is
  no clear industry leader. However, companies
  specialize in some particular sub segments.
• The total number of companies operating in the
  market exceed in numbers. Although more than
  half of he market is covered by the major players
  existing in the market.
• There are more number of international players
  dominating the India POCT market including
  companies such as Abbott, Danaher Corporation,
  Beckman Coulter and others. Companies have
  started setting up their manufacturing units in
  India as well.
• The market share of other companies constitute a
  large amount of 28.0 to 43.0 for the FY2018 as
  the market structure of the industry is
  moderately concentrated.
• Other companies include Hemocue, Atomo
  Diagnostics, Renesas Electronics , Avalun ,
  Wersen ,S D Biocenter, Trivitron Healthcare Pvt
  Ltd, Becton Dickinson India Pvt Ltd and others.
  

Major Players Revenue Share (in ), FY2018
Abbott's India/ Alere India
Roche Diagnostics
Danaher Corporation
J Mitra Co.
Transasia Bio Medical
Bio Rad Laboratories
Siemens Healthcare Private Limited
Beckman Coulter India Pvt Ltd
Diasys India
Others
31
17. Company Profiles of Major Players in India
POCT Market
Abbott India Limited Roche Diagnostics Siemens
Healthcare Pvt. Ltd. Beckman Coulter India Pvt.
Ltd. J Mitra Co. Pvt Ltd. Trans Asia
Biomedical Radiometer India Bio Rad
Labratories DiaSys India Others
32
17.1. Abbott India Limited (1/3)
Table 17.1 Company profile of Abbott India
Limited including Company Overview, Business
Model, Strengths, Market Share, Key POCT Devices
Offered and Mergers Acquisitions
Parameters Description
Company Overview
Business Model
Strengths
Market Share
Key POCT Devices Offered
33
17.1. Abbott India Limited (2/3)
Figure 17.1 Total Income of Abbott India Limited
from All its Brands, FY2015 - FY2017
Table 17.2 Financials of Abbott India Limited
(in INR Million), FY2015, FY2016 and FY2017
Parameters FY15 FY16 FY17
Revenue from Operations
Other Income
Total Income
Total Expenses
EBITA
PAT
Table 17.1 Company profile of Abbott India
Limited including Company Overview, Business
Model, Strengths, Market Share, Key POCT Devices
Offered and Mergers Acquisitions
Parameters Description

Mergers and Acquisitions
34
17.1. Abbott India Limited (3/3)
Table 17.3 Product Portfolio of Blood Glucose
Monitoring Systems of Abbott India Limited
Parameters FreeStyle Lite FreeStyle Freedom Lite FreeStyle InsuLinx FreeStyle Precision Neo
Description
Sample Size
Fast Test Time
Display
Meter Size
Alarms
Ability to Reapply Blood
Test Strip Port Light
Backlight
Alternate Site Testing
Battery Life
Meter Memory
35
Disclaimer
The research reports provided by Ken Research are
for the personal information of the authorized
recipient and is not for public distribution and
should not be reproduced or redistributed without
prior permission. None of this material may be
used for any commercial or public use until
unless authorized by Ken Research. The report
will only be used as per the license rights
authorized by Ken Research. The information
provided in the research documents is from
publicly available data and other sources, which
are reliable. Efforts are made to try and ensure
accuracy of data. With respect to documents
available, neither the company nor any of its
employees makes any warranty, express or implied,
including the warranties of merchantability and
fitness for a particular purpose, or assumes any
legal liability or responsibility for the
accuracy, completeness, or usefulness of any
information, apparatus, product, or process
disclosed, or represents that its use will not
infringe privately owned rights. The report also
includes analysis and views expressed by our
research team. The research reports are purely
for information purposes. The opinions expressed
are our current opinions as of the date appearing
in the material and may be subject to change from
time to time without notice. Investors should not
solely rely on the information contained in the
research documents and must make investment
decisions based on their own investment
objectives, risk profile and financial position.
The recipients of this material should take their
own professional advice before acting on this
information. Ken Research will not accept
returns of reports once dispatched due to the
confidentiality of information provided in our
reports. In case, a report qualify for return, we
will issue a credit, minus shipping charges, of
equal value to the original purchase price,
toward a future purchaseno refunds. The decision
about whether the product return can be accepted
or not is solely at our discretion. Any dispute
will be subject to laws of India and exclusive
jurisdiction of Indian Courts. No part of this
manual or any material appearing may be
reproduced, stored in or transmitted in any other
format without written permission of Ken
Research. This is purely for the reference of the
concerned entity.
36
Contact US
Unit 14, Tower B3, Spaze I Tech Business Park,
Sohna Road, Sector 49, Gurgaon, Haryana -
122001 Office 91 9311149880 Web
www.kenresearch.com Email namit_at_kenresearch.com
Contact Us